Fat Loss & Metabolism
Liraglutide
Saxenda · Victoza · daily GLP-1 agonist
What it is
Liraglutide is the first-generation, daily-injection GLP-1 agonist from Novo Nordisk. FDA-approved for type 2 diabetes (Victoza, 2010) and chronic weight management (Saxenda, 2014). Older sibling to semaglutide — produces less weight loss but with faster onset and easier dose flexibility because it's daily, not weekly.
How it works
Identical mechanism to semaglutide: activates GLP-1 receptors to slow gastric emptying, suppress appetite (via brain pathways), improve insulin response, and reduce food cravings. Half-life is ~13 hours, so requires daily injection.
Benefits
- ~5–8% body weight loss (modest vs. semaglutide's 15%)
- Improved blood glucose and HbA1c
- Cardiovascular event reduction
- Faster onset of appetite suppression
- Dose flexibility — can pause without losing weeks of titration
Timeline
- Day 1–3
- Appetite suppression begins quickly. Common nausea.
- Week 4
- 2–4% weight loss; reduced food cravings.
- Week 12–20
- 5–8% weight loss at full dose.
- Month 6+
- Plateau around 6–8% in most users.
Dosing & titration
Starting dose0.6 mg subQ daily, week 1
Titration (Saxenda)0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg, increasing weekly
Diabetes dose (Victoza)1.2–1.8 mg/day
When to titrate upWeekly if tolerated. Stay at lower dose another week if nausea is rough.
Side effects & risks
- Nausea, vomiting, diarrhea (especially during titration)
- Headache
- Hypoglycemia if combined with insulin/sulfonylureas
- Muscle loss without protein & lifting
- Rare: pancreatitis, gallstones
Black-box warning for medullary thyroid carcinoma in animals. Contraindicated in MEN-2 history.
Typical price
$1,000–$1,400/moBranded Saxenda retail. Compounded liraglutide is rare. Largely being replaced by semaglutide and tirzepatide.
Studies
- Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE) — Pivotal trial. NEJMNEJM, 2015
- Search PubMed for liraglutide — PubMed searchLive PubMed search
Educational reference only. Not medical advice. FDA-approved; requires prescription.